111In-FAP-2286

N/A

Report date: 2025/11/20 16:04:16

Base Information

Drug Name111In-FAP-2286

Drug Alias Name111In-FAP-2286

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Indium > 111In +[4]

Mechanisms of ActionFibroblast activation protein alpha modulators

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies3B Pharmaceuticals GmbH

China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A